Rotavirus

The Vaccine Book

Volumn , Issue , 2003, Pages 225-243

  Bresee, Joseph S ^a   Glass, Roger I ^a   Parashar, Umesh ^a   Gentsch, Jon ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013198590     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012107258-2/50019-6     Document Type: Chapter

References (57)

1. Barnes G.L., Lund J.S., Adams L., Mora A., Mitchell S.V., Caples A., Bishop R.F. Phase 1 trial of a candidate rotavirus vaccine (RV3) derived from a human neonate. J. Pediatr. Child Health 1997, 33:300-304.
2. Bernstein D.I., Glass R.I., Rodgers G., Davidson B.L., Sack D.A. Evaluation of rhesus rotativus, monovalent and tetravalent reassortant vaccines in US children. J. Am. Med. Assoc. 1995, 273:1191-1196.
3. Bernstein D.I., Sack D.A., Rothstein E., Reisinger K., Smith V.E., O'Sullivan D., Spriggs D.R., Ward R.L. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: A randomised placebo-controlled trial. Lancet 1999, 354:287-290.
4. Bhan M.K., Lew J.F., Sazawal S., Das B.K., Gentsch J.R., Glass R.I. Protection conferred by neonatal rotavirus infection against subsequent diarrhea. J. Infect. Dis. 1993, 168:282-287.
5. Bishop R.E., Barnes G.L., Cipriani E., Lund J.S. Clinical immunity after neonatal rotavirus infection: A prospective longitudinal study in young children. New England J. Medicine 1983, 309:72-76.
6. Bishop R.F., Davidson G.P., Holmes I.H., Ruck B.J. Detection of a new virus by electron microscopy of fecal extracts from children with acute gastroenteritis. Lancet 1974, 1:149-151.
7. Brandt C.D., Kim H.W., Rodriguez J.O., Arrobio W.J., Jeffries B.C., Stallings E.P., Lewis C., Miles A.J., Chanock R.M., Kapikian A.Z., Parrott R.H. Pediatric viral gastroenteritis during eight years of study. J. Clin. Microbiol. 1983, 18:71-78.
8. Bresee J., Glass R.I., Ivanoff B., Gentsch J. Current status and future priorities for rotavirus vaccine development, evaluation, and implementation in developing countries. Vaccine 1999, 17:2207-2222.
9. Centers for Disease Control and Prevention Intussusception among recipients of rotavirus vaccine, United States, 1998-1999. Morbidity and Mortality Weekly Report 1999, 48(27):577-581.
10. Centers for Disease Control and Prevention Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 1999, 48(No. RR-2):1-20.
11. Centers for Disease Control and Prevention Withdrawal of rotvvirus vaccine recommendation. Morbidity and Mortality Weekly Report 1999, 48(43):1007.
12. Chang H.G., Smith P.F., Ackelsberg J., Morse D.L., Glass R.I. Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York State. Pediatrics 2001, 108:54-60.
13. Ciarlet M., Crawford S.E., Barone C., Bertolotti-Ciarlet A., Ramikg R.F., Estes M.K., Conner M.E. Subunit rotavirus vaccine administered parenterally to rabbits induces active protective immunity. J. Virol. 1998, 72:9233-9246.
14. Clark H.F., Glass R.I., Offit P.A. Rotavirus vaccines. Vaccines 1999, 987-1005. W.B. Saunders Co., Philadelphia. 3rd ed. S.A. Plotkin, W.A. Orenstein (Eds.).
15. Clark H.F., Offit P.A., Ellis R.W., Eiden J.J., Krah D., Shaw A.R., Pichichero M., Treanor J.J., Borian F.E., Bell L.M., Plotkin S.A. The development of multivalent bovine rotavirus (strain WC3) reassortant, vaccine for infants. J. Infect. Dis. 1996, 174(Suppl. 1):S73-S80.
16. Clark H.F., White C.J., Offit P.A. Preliminary evaluation of safety and efficacy of quadrivalent human-bovine rotavirus vaccine. Pediatr. Res. 1995, 37:172A.
17. Clements-Mann M.L., Makhene M.K., Mrukowicz J., Wright P.F., Hoshino Y., Midthun K., Sperber E., Karron R., Kapikian A.Z. Safety and immunogenicity of live attenuated human-bovine (UK) reassortant rotavirus vaccines with VP7-specificity for serotypes 1, 2, 3, or 4 in adults, children and infants. Vaccine 1999, 17:2715-2725.
18. Das B.K., Gentsch J.R., Hoshino Y., Ishida S.-I., Nakagomi O., Bhan M.K., Kumar R., Glass R.I. Characterization of the G serotype and genogroup of New Delhi newborn rotavirus train 116E. Virology 1993, 197:99-107.
19. de Wit M.A.S., Koopmans M.P.G., van der Blig J.F., van Duynhoven Y.T.H.P. Hospital admissions for rotavirus infection in the Netherlands. Clin. Infect. Dis. 2000, 31:698-704.
20. Estes M.K. Rotaviruses and their replication. Fields Virology 2001, Vol. 2:1747-1785. Lippicot-Raven, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
21. Gentsch J.R., Glass R.I., Woods P., Gouvea V., Gorziglia M., Flores J., Das B.K., Bhan M.K. Identification of group A rotavirus gene 4 types by polymerase chain reaction. J. Clin. Microbiol. 1992, 30:1365-1373.
22. Gentsch J.R., Woods P.A., Ramachandran M., Das B.K., Leite J.P., Alfieri A., Kumar R., Bhan M.K., Glass R.I. Review of G and P typing results from a global collection of strains: Implications for vaccine development. J. Infect. Dis. 1996, 174(Suppl. 1):S30-S36.
23. Glass R.I., Kilgore P.E., Holman R.C., Jin S., Smith J.C., Woods P.A., Clarke M.J., Ho M.S., Gentsch J.R. The epidemiology of rotavirus diarrhea in the United States: Surveillance and estimates of disease burden. J. Infect. Dis. 1996, 174(Suppl. 1):S5-S11.
24. Gurwith M., Wenman W., Gurwith D., Brunton J., Feltham S., Greenberg H. Diarrhea among infants and young children in Canada: A longitudinal study in three northern communities. J. Infect. Dis. 1983, 147:685-692.
25. Herrmann J.E., Chen S.C., Fynan E.F., Santoro J.C., Greenberg H.B., Wang S., Robinson H.L. Protection against rotavirus infections by DNA vaccination. J. Infect. Dis. 1996, 174(Suppl.):S93-S97.
26. Jain V., Parashar U.D., Glass R.I., Bhan M.K. Epidemiology of rotavirus in India: A review to assess the disease burden and potential benefits of a national immunization program. Indian J. Pediatr 2000, in press.
27. Joensuu J., Koskenniemi E., Pang X.-L., Vesikari T. Randomised, double-blind, placebo-controlled trial of rhesus-human, reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997, 350:1205-1209.
28. Kapikian A.Z., Hoshino Y., Chanock R.M. Rotaviruses. Fields Virology 2001, Vol. 1:1787-1834. Lipincott Williams and Wilkins, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
29. Kapikian A.Z., Hoshino Y., Chanock R.M., Perez-Schael I. Efficacy of a quadrivalent rhesus rotavirus-based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children. J. Infect. Dis. 1996, 174(Suppl. 1):S65-S72.
30. Kramarz P., France E.K., Destefano F., Black S.B., Shinefield H., Ward J.I., Chang E.J., Chen R.T., Shatin D., Hill J., Lieu T., Ogren J.M. Population-based study of rotavirus vaccination and intussusception. Pediar. Infect. Dis. J. 2001, 20:410-416.
31. Lanata C.F., Black R.E., Flores J., Lazo F., Butron B., Linares A., Huapaya A., Ventura G., Gil A., Kapikian A.Z. Immunogenicity, safety and protective efficacy of one dose of the rhesus rotavirus vaccine and serotype 1 and 2 human-rhesus rotavirus reassortants in children from Lima, Peru. Vaccine 1996, 14:237-243.
32. Linhares A.C., Gabbay Y.B., Mascarenhas J.D.P., de Freitas R.B., Olivera C.S., Bellesi N., Monteiro T.A.F., Lins-Lainson Z., Ramos F.P., Valente S.A. Immunogenicity, safety and efficacy of tetravalent rhesus-human, reassortant rotavirus vaccine Belem, Brazil. Bull. WHO 1996, 74:491-500.
33. Linhares A.C., Lanata C.F., Hausdorff W.P., Gabbay Y.B., Black R.E. Reappraisal of the Peruvian and Brazilian lower titer tetravalent rhesus-human reassortant rotavirus vaccine efficacy trials: Analysis by severity of diarrhea. Pediatr. Infect. Dis. J. 1999, 18:1001-1006.
34. Lundgren O., Peregrin A.T., Persson K., Kordasti S., Uhnoo I., Svensson L. Role of the enteric nervous system in the fluid and electrolyte secretion of rotavirus diarrhea. Science 2000, 287:491-495. http://www.sciencemag.org.
35. Murphy T.V., Gargiullo P.M., Massoudi M.S., Nelson D.B., Jumaan A.O., Okoro C.A., Zanardi L.R., Setia S., Fair E.L., LeBaron C.W., Schwartz B., Wharton M., Livingood J.R. Intussusception among infants given an oral rotavirus vaccine. New England J. Med. 2001, 344:564-572.
36. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global burden of disease study. Lancet 1997, 349:1436-1442.
37. Nakagomi O., Nakagomi T. Genetic diversity and similarity among mammalian rotaviruses in relation to interspecies transmission of rotavirus. Arch. Virol. 1991, 120:43-55.
38. Offit P.A. Host factors associated with protection against rotavirus disease: The skies are clearing. J. Infect. Dis. 1996, 174(Suppl. 1):S59-S64.
39. Parashar U.D., Holman R.C., Clarke M.J., Bresee J.S., Glass R.I. Hospitalizations associated with rotavirus diarrhea in the United States, 1993 through 1995: Surveillance based on the new ICD-9-CM rotavirus-specific diagnostic code. J. Infect. Dis. 1997, 177:13-17.
40. Pavia A.T., Long E.G., Ryder R.W., Nsa W., Puhr N.D., Wells J.G., Martin P., Tauxe R.V., Griffin P.M. Diarrhea among African children born to human immunod-eficiency virus 1-infected mothers: Clinical, microbiologic and epidemiologic features. Pediatr. Infect. Dis. J. 1992, 11:996-1003.
41. Perez-Schael I., Garcia D., Gonzalez M., Gonzalez R., Daoud N., Perez M., Cunto W., Kapikian A.Z., Flores J. Prospective study of diarrheal diseases in Venezuelan children to evaluate the efficacy of rhesus rotavirus vaccine. J. Med. Virol. 1990, 30:219-229.
42. Perez-Schael I., Guntinas M.J., Perez M., Pagone V., Rojas A.M., Gonzalez R., Cunto W., Hoshino Y., Kapikian A.Z. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela. New Engl. J. Medicine 1997, 337:1181-1209.
43. Ramachandran M., Das B.K., Vij A., Kumar R., Bhambal S.S., Kesari N., Rawat H., Bahl L., Thakur S., Woods P.A., Glass R.I., Bhan M.K., Gentsch J.R. Unusual diversity of human rotavirus G and P genotypes in India. J. Clin. Microbiol. 1996, 34:436-439.
44. Ramachandran M., Gentsch J.R., Parashar U.D., Jin S., Woods P.A., Holmes J.L., Kirkwood C.D., Bishop R.F., Greenberg H.B., Urasawa S., Gerna G., Coulson B.S., Taniguchi K., Bresee J.S., Glass R.I., The National Rotavirus Strain Surveillance System Collaborating Laboratories Detection and characterization of novel rotavirus strain in the United States. J. Clin. Microbiol. 1998, 36:3223-3229.
45. Rennels M.B., Glass R.I., Dennehy P.H., Bernstein D.I., Pichichero M.E., Zito E.T. Safety and efficacy of high-dose rhesus-human reassortant rotavirus vaccines: Report of the national multicenter trial. Pediatrics 1996, 97:7-13.
46. Rennels M.B., Parashar U.D., Holman R.C., Le C.T., Chang H.-G., Glass R.I. Lack of an apparent association between intussusception and wild or vaccine rotavirus infection (brief report). Pediatr. Infect. Dis. J. 1998, 17:924-925.
47. Ryan M.J., Ramsay M., Brown D., Gay N.J., Farrington C.P., Wall P.G. Hospital admissions attributable to rotavirus infection in England and Wales. J. Infect. Dis. 1996, 174(Suppl. 1):S12-S18.
48. Simonsen L., Morens D.M., Elixhauser A., Gerber M., Van Raden M., Blackwelder W. Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception. Lancet 2001, 358:1224-1229.
49. Taniguchi K., Urasawa T., Morita Y., Greenberg H.B., Urasawa S. Direct serotyping of human rotavirus in stools using serotype 1-, 2-, 3-, and 4-specific monoclonal antibodies to VP7. J. Infect. Dis. 1987, 155:1159-1166.
50. Torok T.J., Kilgore P.E., Clarke M.J., Holman R.C., Bresee J.S., Glass R.I. Visualizing geographic and temporal trends in rotavirus activity in the United States, 1991 to 1996. Pediatr. Infect. Dis. J. 1997, 16:941-946.
51. Tucker A.W., Haddix A.C., Bresee J.S., Holman R.C., Parashar U.D., Glass R.I. Cost-effectiveness analysis of a rotavirus immunization program for the United States. J. Am. Med. Assoc. 1998, 279:1371-1376.
52. Unicomb L.E., Kilgore P.E., Faruque A.S.G., Hamadani J.D., Fuchs G.J., Albert M.J., Glass R.I. Anticipating rotavirus vaccines: Hospital-based surveillance for rotavirus diarrhea and estimates of disease burden in Bangladesh. Peiatr. Infect. Dis. J. 1997, 16:947-951.
53. Velazquez F.R., Matson D.O., Calva J.J., Guerrero M.L., Morrow A.L., Carter-Campbell S., Glass R.I., Estes M.K., Pickering L.K., Ruiz-Palacios G.M. Rotavirus infection in infants as protection against subsequent infections. New England J. Medicine 1996, 335:1022-1028.
54. Vesikari T., Isolauri E., D'Hondt E. Protection of infants against rotavirus diarrhead by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984, 1:977-981.
55. Vesikari T., Ruuska T., Koivu H., Green K., Flores J., Kapikian A. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants. Pediatr. Infect. Dis. J. 1991, 10(December):912-917.
56. Ward R.L., Bernstein D.I. Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine 1995, 13:1226-1232.
57. World Health Organization Report of the meeting on future directions for rotavirus vaccine research in developing countries. WHO/V&B 00.23 2000.